Discovery of new organoselenium compounds as antileishmanial agents

Bioorg Chem. 2019 May:86:339-345. doi: 10.1016/j.bioorg.2019.01.069. Epub 2019 Jan 31.

Abstract

We report new organoselenium compounds bearing the sulfonamide moiety as effective inhibitors of the β-isoform of Carbonic Anhydrase from the unicellular parasitic protozoan L. donovani chagasi. All derivatives were evaluated in vitro for their leishmanicidal activities against Leishmania infantum amastigotes along with their cytotoxicities in human THP-1 cells. Compounds 3e-g showed their activity in the low micromolar range with IC50 values spanning from 0.72 to 0.81 µM and selectivity indexes (SI) > 8 (for 3g SI > 30), thus much higher than those observed for the reference drugs miltefosine and edelfosine. This is the first study which reports new selenoderivatives with promising leishmanicidal properties and acting as Carbonic Anhydrase inhibitors too thus paving the way to the development of innovative agents for the treatment of neglected diseases such as leishmaniasis.

Keywords: Carbonic anhydrase; Inhibitor; Leishmania; Metalloenzymes; Selenium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiprotozoal Agents / chemical synthesis
  • Antiprotozoal Agents / chemistry
  • Antiprotozoal Agents / pharmacology*
  • Cell Survival / drug effects
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Drug Discovery*
  • Humans
  • Leishmania infantum / drug effects*
  • Leishmaniasis / drug therapy
  • Molecular Structure
  • Organoselenium Compounds / chemical synthesis
  • Organoselenium Compounds / chemistry
  • Organoselenium Compounds / pharmacology*
  • Parasitic Sensitivity Tests
  • Structure-Activity Relationship
  • THP-1 Cells

Substances

  • Antiprotozoal Agents
  • Organoselenium Compounds